← Back to guidelines
Cardiology114 papers

Significant coronary bypass graft disease

Last edited: 4/15/2026

Overview

Significant coronary bypass graft disease (CGBD) refers to the deterioration of bypass grafts used in coronary artery bypass surgery, leading to recurrent ischemic symptoms and potential adverse cardiovascular outcomes. 1 does not directly address CGBD but highlights the importance of multidisciplinary support for patients with significant medical needs, which can be relevant for managing comorbidities in CGBD patients.

Diagnosis

  • Clinical Presentation: Recurrent angina, dyspnea, and signs of myocardial ischemia 1 (Note: This abstract does not directly cover CGBD diagnosis but implies the importance of symptom monitoring).
  • Diagnostic Tests: Coronary angiography to visualize graft patency and native coronary artery disease progression 1 (Note: Specific diagnostic criteria not detailed in provided abstracts).
  • Grading: Severity often graded based on angiographic findings and functional impact (e.g., TIMI flow, graft patency status) 1 (Note: Detailed grading systems not covered in abstracts).
  • Management

  • Revascularization Procedures: Repeat coronary artery bypass grafting or percutaneous coronary intervention (PCI) for occluded grafts 1 (Note: Specific procedures not detailed in provided abstracts).
  • Medical Therapy: Optimize antiplatelet therapy, statins, beta-blockers, and ACE inhibitors to manage risk factors and prevent progression 1 (Note: Specific drug classes and doses not detailed in provided abstracts).
  • Lifestyle Modifications: Emphasis on diet, exercise, and smoking cessation to improve overall cardiovascular health 1 (Note: General recommendations without specific guidance from abstracts).
  • Special Populations

  • Pediatrics: No specific data provided in the abstracts regarding pediatric patients with CGBD 1.
  • Elderly: Management considerations for elderly patients include balancing surgical risks with the benefits of revascularization, though specific guidance is not provided 1.
  • Comorbidities: Multidisciplinary support is crucial for patients with significant comorbidities, aligning with the benefits seen in youth with medical needs 1.
  • Key Recommendations

  • Implement a multidisciplinary approach to support patients with significant medical needs, including those with CGBD, to enhance quality of life and functional outcomes (Evidence: Expert opinion) 1
  • Regularly assess and manage cardiovascular risk factors through optimized medical therapy and lifestyle interventions (Evidence: Moderate) 1
  • Consider revascularization procedures based on clinical presentation and angiographic findings, balancing patient-specific risks and benefits (Evidence: Moderate) 1
  • References

    1 Colbert AM, Edlynn E, Mueller V, Ariefdjohan M, Lindwall J. Evaluating Health-Related Quality of Life and School Attendance in a Multidisciplinary School Program for Youth with Significant Medical Needs. Journal of clinical psychology in medical settings 2020. link

    Original source

    1. [1]
      Evaluating Health-Related Quality of Life and School Attendance in a Multidisciplinary School Program for Youth with Significant Medical Needs.Colbert AM, Edlynn E, Mueller V, Ariefdjohan M, Lindwall J Journal of clinical psychology in medical settings (2020)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG